Showing results (681-690 of 729) with videos related to

Sort By:
Pageof 73
Investigational New Drugs|October 1, 2013
A phase I, dose-escalation study of the Eg5-inhibitor EMD 534085 in patients with advanced solid tumors or lymphomaA Hollebecque, E Deutsch, C Massard, et al.
Developmental Cognitive Neuroscience|February 15, 2025
Modality-level obstacles and initiatives to improve representation in fetal, infant, and toddler neuroimaging research samplesEmma T Margolis, Paige M Nelson, Abigail Fiske, et al.
Biorxiv : the Preprint Server for Biology|October 17, 2024
Activation of Heme Metabolism Promotes Tissue Health After Intraarticular Injury or Surgical ExposureSuryamin Liman, Piedad C Gomez-Contreras, Madeline R Hines, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 29, 2017
Safety and antitumor activity of the anti-PD-1 antibody pembrolizumab in patients with recurrent carcinoma of the anal canalP A Ott, S A Piha-Paul, P Munster, et al.
Kidney International|August 31, 2024
Myeloperoxidase-ANCA IgG induces different forms of small vessel vasculitis based on type of synergistic immune stimuliPeiqi Hu, Hong Xiao, Marco A Alba, et al.
Neurology|October 22, 2008
Cerebellar leukoencephalopathy: most likely histiocytosis-relatedM S van der Knaap, W F M Arts, J Y Garbern, et al.
International Journal of Molecular Sciences|April 23, 2022
Theophylline: Old Drug in a New Light, Application in COVID-19 through Computational StudiesLuis M Montaño, Bettina Sommer, Juan C Gomez-Verjan, et al.
Clinical and Experimental Immunology|January 14, 2026
IL-33 blockade attenuates vascular inflammation in a mouse model of Kawasaki disease vasculitisThacyana T Carvalho, Benjamin L Ross, Prasant K Jena, et al.
Transplantation Proceedings|March 28, 2018
Tumor Biology as Predictor of Mortality in Liver Transplantation for Hepatocellular CarcinomaL A Caicedo, A Delgado, M Duque, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 11, 2014
Outcome of patients with sarcoma and other mesenchymal tumours participating in phase I trials: a subset analysis of a European Phase I databaseP A Cassier, V Polivka, I Judson, et al.
Pageof 73